Results
|
|
9421.
|
|
|
|
9422.
|
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis. [electronic resource] by
- Bossi, P
- Orlandi, E
- Miceli, R
- Perrone, F
- Guzzo, M
- Mariani, L
- Granata, R
- Locati, L
- Fallai, C
- Cortelazzi, B
- Pilotti, S
- Scaramellini, G
- Gloghini, A
- Licitra, L
Producer: 20141118
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 25
Availability: No items available.
|
|
|
9423.
|
|
|
|
9424.
|
Accuracy of MRI for treatment response assessment after taxane- and anthracycline-based neoadjuvant chemotherapy in HER2-negative breast cancer. [electronic resource] by
- Charehbili, A
- Wasser, M N
- Smit, V T H B M
- Putter, H
- van Leeuwen-Stok, A E
- Meershoek-Klein Kranenbarg, W M
- Liefers, G J
- van de Velde, C J H
- Nortier, J W R
- Kroep, J R
Producer: 20150206
In:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology vol. 40
Availability: No items available.
|
|
|
9425.
|
|
|
|
9426.
|
Serum diamine oxidase activity as a predictor of gastrointestinal toxicity and malnutrition due to anticancer drugs. [electronic resource] by
- Miyoshi, Jinsei
- Miyamoto, Hiroshi
- Goji, Takahiro
- Taniguchi, Tatsuya
- Tomonari, Tetsu
- Sogabe, Masahiro
- Kimura, Tetsuo
- Kitamura, Shinji
- Okamoto, Koichi
- Fujino, Yasuteru
- Muguruma, Naoki
- Okahisa, Toshiya
- Takayama, Tetsuji
Producer: 20160815
In:
Journal of gastroenterology and hepatology vol. 30
Availability: No items available.
|
|
|
9427.
|
|
|
|
9428.
|
A commentary on interstitial pneumonitis induced by docetaxel: clinical cases and systematic review of the literature. [electronic resource] by
- Genestreti, Giovenzio
- Di Battista, Monica
- Trisolini, Rocco
- Denicolò, Fabio
- Valli, Mirca
- Lazzari-Agli, Luigi Arcangelo
- Dalpiaz, Giorgia
- De Biase, Dario
- Bartolotti, Marco
- Cavallo, Giovanna
- Brandes, Alba A
Producer: 20150929
In:
Tumori vol. 101
Availability: No items available.
|
|
|
9429.
|
Phase II trial of miniDOX (reduced dose docetaxel-oxaliplatin-capecitabine) in "suboptimal" patients with advanced gastric cancer (AGC). TTD 08-02. [electronic resource] by
- Rivera, F
- Massutí, B
- Salcedo, M
- Sastre, J
- Martínez Galán, J
- Valladares-Ayerbes, M
- Serrano, R
- García de Paredes, Ma L
- Manzano, J L
- Galán, M
- Alsina, M
- Yuste Izquierdo, A L
- López, C
- Díaz-Rubio, E
- Conde, V
- Reboredo, M
- Cano, Ma T
- Pachón, V
- Aranda, E
Producer: 20150331
In:
Cancer chemotherapy and pharmacology vol. 75
Availability: No items available.
|
|
|
9430.
|
|
|
|
9431.
|
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial. [electronic resource] by
- Garassino, Marina Chiara
- Martelli, Olga
- Broggini, Massimo
- Farina, Gabriella
- Veronese, Silvio
- Rulli, Eliana
- Bianchi, Filippo
- Bettini, Anna
- Longo, Flavia
- Moscetti, Luca
- Tomirotti, Maurizio
- Marabese, Mirko
- Ganzinelli, Monica
- Lauricella, Calogero
- Labianca, Roberto
- Floriani, Irene
- Giaccone, Giuseppe
- Torri, Valter
- Scanni, Alberto
- Marsoni, Silvia
Producer: 20131104
In:
The Lancet. Oncology vol. 14
Availability: No items available.
|
|
|
9432.
|
|
|
|
9433.
|
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology). [electronic resource] by
- Blum, Joanne L
- Flynn, Patrick J
- Yothers, Greg
- Asmar, Lina
- Geyer, Charles E
- Jacobs, Samuel A
- Robert, Nicholas J
- Hopkins, Judith O
- O'Shaughnessy, Joyce A
- Dang, Chau T
- Gómez, Henry Leonidas
- Fehrenbacher, Louis
- Vukelja, Svetislava J
- Lyss, Alan P
- Paul, Devchand
- Brufsky, Adam M
- Jeong, Jong-Hyeon
- Colangelo, Linda H
- Swain, Sandra M
- Mamounas, Eleftherios P
- Jones, Stephen E
- Wolmark, Norman
Producer: 20170908
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 35
Availability: No items available.
|
|
|
9434.
|
|
|
|
9435.
|
|
|
|
9436.
|
Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial. [electronic resource] by
- Rugo, Hope S
- Barve, Abhijit
- Waller, Cornelius F
- Hernandez-Bronchud, Miguel
- Herson, Jay
- Yuan, Jinyu
- Sharma, Rajiv
- Baczkowski, Mark
- Kothekar, Mudgal
- Loganathan, Subramanian
- Manikhas, Alexey
- Bondarenko, Igor
- Mukhametshina, Guzel
- Nemsadze, Gia
- Parra, Joseph D
- Abesamis-Tiambeng, Maria Luisa T
- Baramidze, Kakhaber
- Akewanlop, Charuwan
- Vynnychenko, Ihor
- Sriuranpong, Virote
- Mamillapalli, Gopichand
- Ray, Sirshendu
- Yanez Ruiz, Eduardo P
- Pennella, Eduardo
Producer: 20170209
In:
JAMA vol. 317
Availability: No items available.
|
|
|
9437.
|
Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621. [electronic resource] by
- Hurwitz, Mark D
- Harris, Jonathan
- Sartor, Oliver
- Xiao, Ying
- Shayegan, Bobby
- Sperduto, Paul W
- Badiozamani, Kasra R
- Lawton, Colleen A F
- Horwitz, Eric M
- Michalski, Jeff M
- Roof, Kevin
- Beyer, David C
- Zhang, Qiang
- Sandler, Howard M
Producer: 20170828
In:
Cancer vol. 123
Availability: No items available.
|
|
|
9438.
|
A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer. [electronic resource] by
- Abramson, Vandana G
- Oliveira, Mafalda
- Cervantes, Andrés
- Wildiers, Hans
- Patel, Manish R
- Bauer, Todd M
- Bedard, Philippe L
- Becerra, Carlos
- Richey, Stephen
- Wei, Michael C
- Reyner, Eric
- Bond, John
- Cui, Na
- Wilson, Timothy R
- Moore, Heather M
- Saura, Cristina
- Krop, Ian E
Producer: 20200219
In:
Breast cancer research and treatment vol. 178
Availability: No items available.
|
|
|
9439.
|
|
|
|
9440.
|
|